Autoimmune responses against oxidant stress and acetaldehyde-derived epitopes in human alcohol consumers

Alcoholism: Clinical and Experimental Research

Volumn 24, Issue 7, 2000, Pages 1103-1109

  Viitala, Katja ^a   Makkonen, Kati ^a   Israel, Yedy ^b   Lehtimäki, Terho ^c   Jaakkola, Olli ^c   Koivula, Timo ^c   Blake, Joan E ^d   Niemelä, Onni ^a  

^a EP Central Hospital Laboratory   (Finland)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Autoantibodies; Ethanol Metabolism; Liver Disease

Indexed keywords

ACETALDEHYDE; ALCOHOL; AUTOANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MALONALDEHYDE;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOLISM; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBROGENESIS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALIA;

EID: 0033861032     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000374-200007000-00023     Document Type: Article

References (44)

1. Albano E, Clot P, Morimoto M, Tomasi A, Ingelman-Sundberg M, French SW (1996) Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology 23:155-163.
2. Amore A, Coppo R, Roccatello D, Piccoli G, Mazzucco G, Gomez-Chiarri M, Lamm ME, Emancipator SN (1994) Experimental IgA nephropathy secondary to hepatocellular injury induced by dietary deficiencies and heavy alcohol intake. Lab Invest 70:68-77.
3. Behrens UJ, Hoerner M, Lasker JM, Lieber CS (1988) Formation of acetaldehyde adducts with ethanol-inducible P450IIE1 in vivo. Biochem Biophys Res Commun 154:584-590.
4. Blake J, Orrego H (1991) Monitoring treatment of alcoholic liver disease: Kevaluation of various severity indices. Clin Chem 37:5-13.
5. Border WA, Noble NA (1994) Transforming growth factor β in tissue fibrosis. N Engl J Med 331:1286-1292.
6. Brown WR, Kloppel TM (1989) The liver and IgA: Immunological, cell biological and clinical implications. Hepatology 9:763-784.
7. Clot P, Albano E, Eliasson E, Tabone M, Arico S, Israel Y, Moncada C, Ingelman-Sundberg M (1996) Cytochrome P450IIE1 hydroxyethyl radical adducts as the major antigen in autoantibody formation among alcoholics Gastroenterology 111:206-216.
8. Clot P, Bellomo G, Tabone M, Arico S, Albano E (1995) Detection of antibodies against proteins modified by hydroxyethyl free radicals in patients with alcoholic cirrhosis. Gastroenterology 108:201-207.
9. Haberland ME, Fogelman AM, Edwards PA (1982) Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. Proc Natl Acad Sci USA 79:1712-1716.
10. Halsted CH, Villanueva J, Chandler CJ, Ruebner B, Munn RJ, Parkkila S, Niemelä O (1993) Centrilobular distribution of acetaldehyde and collagen in the ethanol-fed micropig. Hepatology 18:954-960.
11. Hoerner M, Behrens UJ, Worner TM, Blacksberg I, Braly LF, Schaffner F, Lieber CS (1988) The role of alcoholism and liver disease in the appearance of serum antibodies against acetaldehyde adducts. Hepatology 8:569-574.
12. Holstege A, Bedossa P, Poynard T, Kollinger M, Chaput JC, Houglum K, Chojkier M (1994) Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: Localization and association with progression of liver fibrosis. Hepatology 19:367-372.
13. Israel Y, Hurwitz E, Niemelä O, Arnon R (1986) Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts. Proc Natl Acad Sci USA 83:7923-7927.
14. Israel Y, Orrego H, Niemelä O (1988) Immune responses to alcohol metabolites: Pathogenesis and diagnostic implications. Semin Liver Dis 8:81-90.
15. Izumi N, Sakai Y, Koyama W, Hasumura Y (1989) Clinical significance of serum antibodies against alcohol-altered hepatocyte membrane in alcoholic liver disease. Alcohol Clin Exp Res 13:762-765.
16. Johnson KJ, Chensue SW, Kunkel SL, Ward PA: Immunopathology, in Rubin E, Farber JL (ed): Pathology, (ed 2). Philadelphia, JB Lippincott 1994:p 97-142.
17. Johnson RD, Williams R (1986) Immune responses in alcoholic liver disease. Alcohol Clin Exp Res 10:471-485.
18. Kerr MA (1990) The structure and function of human IgA. Biochem J 271:285-296.
19. Koskinas J, Kenna JG, Bird GL, Alexander GJM, Williams R (1992) Immunoglobulin A antibody to a 200-kilodalton cytosolic acetaldehyde adduct in alcoholic hepatitis. Gastroenterology 103:1860-1867.
20. Lehtimäki T, Lehtinen S, Solakivi T, Nikkilä M, Jaakkola O, Jokela H, Ylä-Herttuala S, Luoma JS, Koivula T, Nikkari T (1999) Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. Arterioscler Thromb Vase Biol 19:23-27.
21. Lieber CS (1995) Medical disorders of alcoholism. N Engl J Med 333: 1058-1065.
22. Lin RC, Shahidi S, Lumeng L (1993) Production of antibodies that recognize the heterogeneity of immunoreactive sites in human hemoglobin chemically modified by acetaldehyde. Alcohol Clin Exp Res 17:882-886.
23. Marshall JB, Burnett DA, Zetterman RK, Sorrell MF (1983) Clinical and biochemical course of alcoholic liver disease following sudden discontinuation of alcoholic consumption. Alcohol Clin Exp Res 7:312-315.
24. Mauch TJ, Donohue TM, Zettermann RK, Sorrell MF, Tuma DJ (1986) Covalent binding of acetaldehyde selectively inhibits the catalytic activity of lysine-dependent enzymes. Hepatology 6:263-269.
25. Niemelä O, Juvonen T, Parkkila S (1991) Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption. J Clin Invest 87:1367-1374.
26. Niemelä O, Klajner F, Orrego H, Vidins E, Blendis L, Israel Y (1987) Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. Hepatology 7:1210-1214.
27. Niemelä O, Parkkila S, Ylä-Herttuala S, Halsted C, Witztum JL, Lanca A, Israel Y (1994) Covalent protein adducts in the liver as a result of ethanol metabolism and lipid peroxidation. Lab Invest 70:537-546.
28. Niemelä O, Parkkila S, Ylä-Herttuala S, Villanueva J, Ruebner B, Halsted CH (1995) Sequential acetaldehyde production, lipid peroxidation and fibrogenesis in micropig model of alcohol-induced liver disease. Hepatology 22:1208-1214.
29. Orrego H, Blake JE, Blendis LM, Medline A (1987) Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology 92:208-214.
30. Orrego H, Israel Y, Blake JE, Medline A (1983) Assessment of prognostic factors in alcoholic liver disease: Toward a global quantitative expression of severity. Hepatology 3:896-905.
31. Paradis V, Scoazec J-Y, Köllinger M, Holstege A, Moreau A, Feldmann G, Bedossa P (1996) Cellular and subcellular localization of acetaldehyde-protein adducts in liver biopsies from alcoholic patients. J Histochem Cytochem 44:1051-1057.
32. Salaspuro M (1996) Bacteriocolonic pathway for ethanol oxidation: characteristics and implications. Ann Med 28:195-200.
33. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum JL (1992) Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339: 883-887.
34. Schenker S (1997) Medical consequences of alcohol abuse: is gender a factor? Alcohol Clin Exp Res 21(1):179-181.
35. Seitz HK, Gartner U, Egerer G, Simanowski UA (1994) Ethanol metabolism in the gastrointestinal tract and its possible consequences. Alcohol Alcohol 2:157-162.
36. Tuma DJ, Klassen LW (1992) Immune responses to acetaldehyde-protein adducts: Role in alcoholic liver disease. Gastroenterology 103:1969-1973.
37. Tuma DJ, Newman MR, Donohue TM, Sorrell MF (1987) Covalent binding of acetaldehyde to proteins: Participation of lysine residues. Alcohol Clin Exp Res 11:579-584.
38. van de Wiel A, Delacroix DL, van Hattum J, Schuurman H-J, Kater L (1987) Characteristics of serum IgA and liver IgA deposits in alcoholic liver disease. Hepatology 7:95-99.
39. van de Wiel A, van Hattum J, Schuurman H-J, Kater L (1988) Immunoglobulin A in the diagnosis of alcoholic liver disease. Gastroenterology 94:457-462.
40. Viitala K, Israel Y, Blake JE, Niemelä O (1997) Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-modified epitopes: Relationship to liver disease severity and alcohol consumption. Hepatology 25:1418-1424.
41. Visapää J-P, Jokelainen K, Nosova T, Salaspuro M (1998) Inhibition of intracolonic acetaldehyde production and alcoholic fermentation in rats by ciprofloxacin. Alcohol Clin Exp Res 22:1161-1164.
42. Worrall S, de Jersey J, Shanley BC, Wilce PA (1991) Antibodies against acetaldehyde-modified epitopes: An elevated IgA response in alcoholics. Eur J Clin Invest 21:90-95.
43. Xu D, Thiele GM, Beckenhauer JL, Klassen LW, Sorrell MF, Tuma DJ (1998) Detection of circulating antibodies to malondialdehyde-acetaldehyde adducts in ethanol-fed rats. Gastroenterology 115:686-692.
44. Yokoyama H, Nagata S, Moriya S, Kato S, Ito K, Kamegaya K, Ishii H (1995) Hepatic fibrosis produced in guinea pigs by chronic ethanol administration and immunization with acetaldehyde adducts. Hepatology 21:1438-1442.